Neuropsychiatric Disease and Treatment (Dec 2020)
Body Dysmorphic Disorder, Psychiatric Symptoms, and Quality of Life in Female Dermatological Patients
Abstract
Ik-Seung Chee, 1, 2 Hyun-Jin Kim, 2 Young Lee, 3 Jee Wook Kim 4, 5 1Department of Psychiatry, Chungnam National University Hospital, Daejeon, Republic of Korea; 2Department of Psychiatry, Chungnam National University Sejong Hospital, Sejong, Republic of Korea; 3Department of Dermatology, Chungnam National University Hospital, Daejeon, Republic of Korea; 4Department of Neuropsychiatry, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Gyeonggi, Republic of Korea; 5Department of Psychiatry, Hallym University College of Medicine, Chuncheon, Gangwan, Republic of KoreaCorrespondence: Jee Wook KimDepartment of Neuropsychiatry, Hallym University Dongtan Sacred Heart Hospital, 7 Keunjaebong-gil, Hwaseong-si, Gyeonggi-do 18450, Republic of KoreaTel +82 31 8086 2340Fax +82 31 8086 2029Email [email protected]: To examine the relationships of body dysmorphic disorder (BDD) with psychiatric symptoms and quality of life in dermatological patients.Patients and Methods: A total of 154 female patients with dermatological disease underwent a comprehensive clinical assessment that included the Body Dysmorphic Disorder Examination-Self Report (BDDE-SR), Symptom Checklist 90-Revised (SCL-90-R), and Skindex-29. Dermatological disease was categorized as follows: inflammatory dermatoses (reference category), isolated lesions, and unclassified dermatoses. The BDDE-SR and SCL-90-R scores were used to evaluate BDD and psychiatric symptoms, respectively. Dermatological quality of life was measured with the Skindex-29.Results: The BDDE-SR score was significantly associated with the SCL-90-R and Skindex-29 total and subscores, even after controlling for age, body mass index, and dermatological diagnosis. The variables that contributed most to the BDDE-SR score were the SCL-90-R depression score and Skindex-29 emotion scores. Additional analyses revealed that the BDDE-SR score was higher in participants with unclassified dermatoses, but neither the SCL-90-R score nor Skindex-29 score was related to any dermatological diagnosis.Conclusion: The BDD symptoms were especially prominent in the unclassified dermatoses group and were highly related to psychiatric symptoms and a poor quality of life in our dermatological patients. Further research including studies involving psychiatric interviews to confirm the BDD diagnosis and symptoms will improve our understanding of BDD in dermatological patients.Keywords: body dysmorphic disorder, psychiatric symptoms, quality of life: dermatological disease, unclassified dermatoses
